白藜芦醇抑制伤口愈合与晶状体纤维化:后囊膜混浊预防的候选药物
本研究利用人晶状体上皮细胞系FHL124、人晶状体囊袋模型及中央前囊膜上皮,探讨白藜芦醇(RESV)对后囊膜混浊(PCO)相关生理事件的作用。结果显示30 μM RESV可显著抑制细胞迁移、基质收缩、囊袋内细胞生长及TGFβ2诱导的α-SMA表达与囊膜皱缩,提示RESV有潜力作为预防PCO的候选药物。
要点
- 30 μM RESV显著抑制FHL124细胞划痕实验中的细胞迁移。
- RESV显著抑制TGFβ2诱导的α-SMA表达及基质收缩。
- 人囊袋模型中30 μM RESV显著抑制细胞生长、α-SMA表达与囊膜皱缩。
核心结论
- RESV可在两种人晶状体模型系统中对抗PCO相关生理事件,因此有潜力作为预防PCO的候选药物,可能惠及数百万白内障患者。
研究设计与样本
- 实验系统包括人晶状体上皮细胞系FHL124、人晶状体囊袋模型及中央前囊膜上皮。
- 常规培养于含5%胎牛血清的Eagle最低必需培养基,用10 ng/mL转化生长因子-β2(TGFβ2)诱导纤维化改变。
- 采用划痕伤口实验测定细胞迁移,斑块实验评估FHL124细胞基质收缩。
- 蛋白表达用免疫细胞化学和蛋白质印迹评估,基因表达用定量RT-PCR评估。
- 在囊袋模型中通过图像分析测定细胞跨后囊生长、囊膜皱缩及上皮-间质转化。
主要发现
- 在FHL124细胞中,加入30 μM RESV显著阻碍划痕愈合实验中的细胞迁移。
- RESV在mRNA和蛋白水平均显著抑制TGFβ2诱导的肌成纤维细胞标志物α-平滑肌肌动蛋白(α-SMA)表达,并显著抑制TGFβ2诱导的基质收缩。
- 在人囊袋中,30 μM RESV显著抑制细胞生长;TGFβ2诱导的α-SMA表达和囊膜皱缩也被RESV显著抑制。
- RESV显著抑制TGFβ2诱导的纤维化疾病相关基因表达,包括在FHL124细胞、囊袋及中央前囊膜上皮中的基质金属蛋白酶-2。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Posterior capsule opacification (PCO) is a common complication of cataract surgery. In addition to improved surgical methods and IOL designs, it is likely additional agents will be needed to improve patient outcomes. Presently no pharmacological agent is in clinical use to prevent PCO. Here we investigate the putative ability of resveratrol (RESV), a naturally occurring polyphenol, as a therapeutic agent. METHODS: The human lens epithelial cell line FHL124, a human lens capsular bag model, and central anterior epithelium were used as experimental systems. Standard culture was in 5% fetal calf serum Eagle's minimum essential medium; 10 ng/mL transforming growth factor-β2 (TGFβ2) was used to induce fibrotic changes. A scratch wound assay was used to measure cell migration and the patch assay was used to assess matrix contraction by FHL124 cells. Protein expression was assessed by immunocytochemistry and Western blot and gene expression by quantitative RT-PCR. In capsular bags, cell growth across the posterior lens capsule, capsular wrinkling, and epithelial-to-mesenchymal transition were determined by image analysis. RESULTS: In FHL124 cells, addition of 30 μM RESV significantly impeded cell migration in a wound-healing assay. RESV significantly inhibited TGFβ2-induced expression of the myofibroblast marker alpha-smooth muscle actin (α-SMA) at both the message and protein levels, as well as significantly inhibiting matrix contraction induced by TGFβ2. In human capsular bags, 30 μM RESV significantly inhibited cell growth. TGFβ2-induced α-SMA expression and capsular wrinkling were also significantly inhibited by RESV treatment. RESV significantly suppressed expression of TGFβ2-induced genes associated with fibrotic disease, including matrix metalloproteinase-2 in FHL124 cells, capsular bags, and central anterior epithelium. CONCLUSIONS: RESV can counter PCO-related physiological events in two human lens model systems. RESV therefore has the potential to be used as a candidate agent for the prevention of PCO, which in turn could benefit millions of cataract patients.
引用
- Smith AJO, Eldred JA, Wormstone IM, et al. Resveratrol Inhibits Wound Healing and Lens Fibrosis: A Putative Candidate for Posterior Capsule Opacification Prevention. Invest Ophthalmol Vis Sci. 2019. PMID: 31529119. doi:10.1167/iovs.18-26248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。